Market Chameleon (Tue, 23-Dec 5:30 AM ET)
Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months
Globe Newswire (Tue, 23-Dec 8:00 AM ET)
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Bone Biologics trades on the NASDAQ stock market under the symbol BBLG.
As of December 31, 2025, BBLG stock price declined to $1.45 with 39,011 million shares trading.
BBLG has a beta of 0.42, meaning it tends to be less sensitive to market movements. BBLG has a correlation of 0.01 to the broad based SPY ETF.
BBLG has a market cap of $2.60 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, BBLG traded as high as $4,608.05 and as low as $1.30.
BBLG has underperformed the market in the last year with a price return of -74.3% while the SPY ETF gained +17.6%. BBLG has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -48.0% and -27.5%, respectively, while the SPY returned +2.7% and +1.9%, respectively.
BBLG support price is $1.38 and resistance is $1.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BBLG shares will trade within this expected range on the day.
